Photo Credit: Wesley Gibbs
Scientific Frontline: Extended "At a Glance" Summary: Adolescent Cannabis Use and Dopamine System Alteration
The Core Concept: Chronic cannabis use during adolescence significantly lowers tissue iron levels in dopamine-rich brain regions, indicating a disruption in the maturation of the brain's reward system.
Key Distinction/Mechanism: Unlike standard behavioral addiction studies, this research employs magnetic resonance imaging (MRI) to measure tissue iron—a necessary cofactor for dopamine production—as a direct, noninvasive biomarker. It demonstrates that cannabis uniquely impedes early neural development because exogenous cannabinoids disrupt the endogenous endocannabinoid system, which naturally regulates the maturation of these critical high-dopamine circuits.
Major Frameworks/Components:
- Tissue Iron Biomarkers: Utilized as a proxy for healthy dopamine system maturation, as physiological iron must naturally increase during adolescence for dopamine synthesis.
- Magnetic Resonance Imaging (MRI): The noninvasive imaging modality used to quantify the distribution of tissue iron in specific brain regions.
- Endocannabinoid System (ECS): The endogenous neurochemical network targeted by cannabis, identified as a primary facilitator of early brain development in high-dopamine regions.
- Cannabis Use Disorder (CUD) Metrics: Variables including use frequency, quantity, duration of intoxication, and addiction severity were found to have a negative, dose-dependent association with tissue iron markers.
Branch of Science: Neuropsychopharmacology, Developmental Neuroscience, and Psychiatry.
Future Application: The establishment of noninvasive neuroimaging biomarkers (tissue iron tracking) enables longitudinal monitoring of the dopamine system. This will guide subsequent studies tracking neural health over time and may inform targeted clinical interventions for adolescent addiction vulnerability.
Why It Matters: With 10% to 20% of U.S. adolescents reporting cannabis use and the clinical availability of exceptionally high-potency products, establishing a direct physiological link between early use and altered reward circuitry underscores a profound risk for permanent deficits in motivation, learning, and addiction resilience.
A new study shows that among adolescents who use cannabis, the drug may interfere with the brain’s reward system at a time of crucial development, and higher-potency cannabis products have more pronounced effects.
“Adolescence is a critical window for brain development,” said lead study author Sarah A. Thomas, an assistant professor of psychiatry and human behavior (research) at Brown University’s Warren Alpert Medical School and a clinical psychologist at Brown University Health’s Bradley Hasbro Children's Research Center. “Our findings suggest that repeated cannabis use during this period has the potential to alter the dopamine system in ways that could affect motivation, reward processing, and vulnerability to addiction.”
Previous research has found that approximately 10% to 20% of US adolescents report using cannabis, and studies in humans and animals provide strong evidence that adolescence is a vulnerable period to start using the drug because it interferes with the brain’s development process. Cannabis use during the adolescent years, compared to adulthood, is linked to a higher risk of developing a cannabis use disorder and experimenting with other drugs. One possible reason is that cannabis disrupts the brain’s dopamine system—the circuits that help regulate motivation, learning, and reward.
In a federally funded study with 81 participants aged 14 to 17, the researchers assessed cannabis use quantity, frequency, and cannabis use disorder severity. They then used magnetic resonance imaging to measure tissue iron in brain regions with high dopamine activity. Tissue iron is a necessary factor in the production of dopamine and naturally increases during adolescence as the dopamine system matures, the researchers said, making it a useful indicator of healthy development.
The study found that in many brain regions, adolescents who use cannabis had significantly lower tissue iron levels than those with little to no use. Results showed that cannabis use quantity, frequency, hours spent under the influence, and cannabis use disorder severity were negatively associated with markers for tissue iron.
The researchers state the study is the first to examine how cannabis use in adolescents relates to tissue iron levels in the brain—a reliable, noninvasive marker linked to dopamine activity. The results, they note, add to growing evidence that cannabis use by adolescents may have negative effects on brain development, making individuals who use cannabis more vulnerable to addiction.
“There seems to be something unique about using cannabis—compared to nicotine or alcohol—during adolescence, because the body's own endocannabinoid system is what is helping to facilitate developing these brain regions, especially in these regions that are high in dopamine,” Thomas said. “And the regions that are high in dopamine tend to develop earlier than other parts of the brain.”
The results are particularly concerning, Thomas said, given the significant increase in the potency of cannabis products compared to just a decade ago.
“The cannabis that people are using is incredibly strong, and higher potency is linked to more adverse outcomes,” Thomas said.
The findings highlight the importance of understanding how early cannabis use shapes long-term outcomes. As a next step, the research team is studying how cannabis use affects the dopamine system over time.
Funding: The study was funded by the National Institute on Drug Abuse (K23DA050911), National Institutes of Health COBRE Awards (P30GM149405, P20GM139743), the National Institute of General Medical Sciences (U54GM115677), the Brain and Behavior Research Foundation, and the Zorich Family Foundation.
Published in journal: Neuropsychopharmacology
Authors: Sarah A. Thomas, Meghan A. Gonsalves, Gillian LeBlanc, Elizabeth Lorenc, Jane Metrik, Michael Frank, Sarah Ryan, Emily Olenik, Leslie Brick, Anthony Spirito, and Jodi Gilman
Source/Credit: Brown University
Edited by: Scientific Frontline
Reference Number: ns060626_01
.jpg)